In vitro diagnostics specialists today have to design systems capable of carrying out increasingly complex tests while making the results easier to interpret. HORIBA Medical has risen to the challenge by considerably intensifying its research efforts. The company aims to invest over 10% of its sales in R&D in the medium term.
Many new concepts, that are unique, have been introduced in the field of in vitro diagnostics, including the most compact system on the market (Micros designed by HORIBA Medical).
Over 40 “key” patent families have been lodged worldwide, covering all the technologies included in our testing systems.

Indicadores claves

  • Más del 900 empleados
  • 3 plantas de producción en todo el mundo (Montpellier, Kioto y San Pablo)
  • Más del 8% de los ingresos destinados a la investigación

19/03/2020 - Together, we will cross and overcome this epidemic.

Read more

13/03/2020 - Yumizen G200 confirmed as suitable for blood coagulation external quality assessment testing

Read more

24/01/2020 - Two parties have signed a contract to meet the company’s requirements of biological samples for the...

Read more